Nascent Biotech Inc (NBIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Nascent Biotech Inc (Nascent) is a clinical-stage biopharmaceutical company. The company delivers human monoclonal antibodies and cytokine for the treatment of cancer and drug discovery platform for identifying new antibodies and antigens for commercialization. It develops Pritumumab, a monoclonal antibody to treat patients with brain cancer malignancies such as glioblastoma and malignant astrocytoma, lung and breast cancer metastases to the brain; and pancreatic cancer. The company offers CLNH5 and MultiPharm, a platform technology proprietary, which have additive and synergistic effects on cancer therapy, diabetes, autoimmunity, and transplantation. Nascent is headquartered in Vero Beach, Florida, the US.

Nascent Biotech Inc (NBIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
Nascent Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nascent Biotech Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Nascent Biotech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nascent Biotech Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Nascent Biotech Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Nascent Biotech Inc, Pharmaceuticals & Healthcare, Deal Details 10
Licensing Agreements 10
Zhejiang Hisun Pharma Enters into Licensing Agreement with Nascent Biotech 10
Equity Offering 11
Nascent Biotech Raises USD1.15 Million in Second Tranche Public Offering of Shares 11
Nascent Biotech to Raise Funds through Public Offering 12
Nascent Biotech Raises USD0.3 Million in First Tranche of Public Offering of Shares 13
Nascent Biotech Raises USD1.2 Million in Private Placement of Shares 14
Nascent Biotech Inc - Key Competitors 15
Nascent Biotech Inc - Key Employees 16
Nascent Biotech Inc - Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List Of Tables


Nascent Biotech Inc, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Nascent Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nascent Biotech Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Nascent Biotech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nascent Biotech Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Nascent Biotech Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Zhejiang Hisun Pharma Enters into Licensing Agreement with Nascent Biotech 10
Nascent Biotech Raises USD1.15 Million in Second Tranche Public Offering of Shares 11
Nascent Biotech to Raise Funds through Public Offering 12
Nascent Biotech Raises USD0.3 Million in First Tranche of Public Offering of Shares 13
Nascent Biotech Raises USD1.2 Million in Private Placement of Shares 14
Nascent Biotech Inc, Key Competitors 15
Nascent Biotech Inc, Key Employees 16

List Of Figures


Nascent Biotech Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Nascent Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Nascent Biotech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Nascent Biotech Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Nascent Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nascent Biotech Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Nascent Biotech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nascent Biotech Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Nascent Biotech Inc (NBIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Nascent Biotech Inc (Nascent) is a clinical-stage biopharmaceutical company. The company delivers human monoclonal antibodies and cytokine for the treatment of cancer and drug discovery platform for identifying new antibodies

USD 250 View Report

Krystal Biotech Inc (KRYS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Krystal Biotech Inc (Krystal Biotech) is a drug development company that uses gene therapy to develop novel treatments for skin diseases. The companys pipeline products include KB103, KB105, and KB200.

USD 250 View Report

JHL Biotech Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

JHL Biotech Inc (JHL Biotech) is a biologic medicines provider. The company offers cell line construction, process development, manufacturing, quality and regulatory services. It offers products such as biosimilar rituximab,

USD 250 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available